Merck & Co Inc at Goldman Sachs Healthcare Conference Transcript
We're just about at time. So let's keep moving with our next session with Merck. I'm very excited to have Rob Davis, CEO and Dean Li, EVP, Research Labs. Thank you both for being with us today.
Questions & Answers
Rob, maybe before we begin, I want to just give you the opportunity to level set up big picture on how things are going, sort of midpoint of the year, how are things tracking toward the de-risking of the commercial targets that you said that you've achieved at least half of by the end of this year. So high-level comments on those.
Yeah. Happy to do it. Well, one, thank you for having us. Good afternoon, everyone. If you look at where we're at, it's already been a very eventful year for us so far. And I would say our transformation is well underway.
If you look at the readouts we've had, it's pretty much hitting every area of our portfolio, whether it's
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
